General MedicationsINJECTIONGeneric

GARAMYCIN

GENTAMICIN SULFATE

Standard Dose

EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview GARAMYCIN is listed in Drugs@FDA under application 061716 (ANDA).

Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1999-01-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview GARAMYCIN is listed in Drugs@FDA under application 061716 (ANDA). Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1999-01-04 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.